Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

November 10, 2023 Updated IASLC - Hindi
Title:
Lung Cancer Care in India: Approaching a Lung Cancer Diagnosis (Hindi language podcast)
The podcast is recorded in Hindi and covers a range of crucial lung cancer topics, including the emergence of adenocarcinoma as the dominant histological type, delays in diagnosis related to misdiagnosis as tuberculosis, and the importance of accurate staging and biomarker testing.
51 min
November 06, 2023 FDA Approval: Encorafenib + Binimetinib in BRAF V600E NSCLC
In this podcast, host Dr. Stephen Liu moderates a discussion a recent FDA approval and a specific molecular subtype of NSCLC. On October 11, 2023, the US FDA granted approval to encorafenib and binimetinib for advanced NSCLC harboring a BRAF V600E mutation based on the phase II PHAROS trial.
43 min
November 01, 2023 ESMO 2023 Highlights: Early Stage NSCLC, SCLC, Thymic Carcinoma
Part 2 of our podcast coverage on ESMO 2023 includes an in-depth interview with Dr. Jarushka Naidoo on early-stage NSCLC, including updates from CheckMate816, Keynote 671 overall survival results, and Checkmate77T, first perceptions about the data, remaining unanswered questions and how to incorporate to our clinical practice. Further, we discussed exciting data in the 2nd line setting for Small-Cell Lung Cancer and a new potential therapeutic option for thymic carcinoma. Tune in for this thought-provoking, data-driven, and practical episode of Lung Cancer Considered.
46 min
October 30, 2023 ESMO 2023 Highlights: Metastatic NSCLC
In the first part of two podcasts covering recent data presented at the European Society of Medical Oncology Congress 2023, host Dr. Stephen Liu summarizes the most compelling research on metastatic non small cell lung cancer from the meeting with Dr. Zosia Piotrowska and Dr. Noemi Reguart, discussing several impactful studies including MARIPOSA, MARIPOSA-2, LIBRETTO-431, TROPION-Lung01 and more as well as reviewing the importance of CNS efficacy and the evolving role of antibody drug conjugates (ADCs).
46 min
October 27, 2023 Lung Cancer Care and Research in Japanese
Today’s episode of Lung Cancer Considered is recorded entirely in Japanese and focuses on EGFR mutated lung cancer.
55 min
October 24, 2023 Lung Cancer Considered--Hungarian Episode
In this special episode of Lung Cancer Considered recorded in Hungarian, lung cancer experts in Hungary and the United States discuss challenges and emerging strategies to treat lung cancer in Hungary.
1 hr 3 min
October 17, 2023 IASLC - Virtual Tumor Board Stage III NSCLC (1)
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the role of neoadjuvant therapy for stage III NSCLC using a virtual tumor board format. This area has become increasingly complex of late, as we have seen several large studies report encouraging results with peri-operative immunotherapy and targeted therapy.
48 min
October 17, 2023 IASLC - Mesothelioma
Mesothelioma is a particularly challenging cancer to treat and there had been relatively few updates in its management until the recent integration of immunotherapy into treatment guidelines. To discuss current strategies to treat Mesothelioma, Dr. Stephen Liu leads an informed discussion with two international Mesothelioma experts.
44 min
October 03, 2023 NACLC 2023 Preview
In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu preview the 2023 North America Conference on Lung Cancer, scheduled for December in Chicago, December 1 - 3. The deadline for abstract submission is October 26th. Visit https://www.iaslc.org/2023-north-america-conference-lung-cancer to learn more.
19 min
September 19, 2023 WCLC 2023 - Meeting Wrap Up
Lung Cancer Considered Hosts Dr. Narjust Florez and Dr. Stephen Liu wrap up WCLC 2023 in Singapore, discussing the meeting's most impactful research, including MARS2, FLAURA2, TRIDENT, HERTHENA, and TROPION.
50 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.